Simethicone-cellulose
Sonorx (simethicone-cellulose) is a small molecule pharmaceutical. Simethicone-cellulose was first approved as Sonorx on 1998-10-29. It is used to treat flatulence in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
|---|---|
| signs and symptoms pathological conditions | D013568 |
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Simethicone-cellulose
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| SONORX | Bracco Diagnostics | N-020773 DISCN | 1998-10-29 | 1 products |
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| flatulence | — | D005414 | R14.3 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
114 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Colonoscopy | D003113 | — | — | 1 | — | 2 | 5 | 4 | 12 |
| Healthy volunteers/patients | — | — | — | 8 | — | — | 1 | 1 | 10 |
| Irritable bowel syndrome | D043183 | EFO_0000555 | K58 | 1 | — | — | 3 | 2 | 6 |
| Dyspepsia | D004415 | EFO_0008533 | K30 | 1 | — | 2 | 1 | 1 | 5 |
| Capsule endoscopy | D053704 | — | — | — | — | — | 1 | 4 | 5 |
| Diarrhea | D003967 | — | R19.7 | — | 1 | 1 | 2 | 1 | 5 |
| Colonic polyps | D003111 | — | K63.5 | — | — | 1 | 2 | 2 | 5 |
| Colic | D003085 | — | R10.83 | — | 1 | — | 1 | 2 | 4 |
| Adenoma | D000236 | — | — | — | — | — | 1 | 2 | 3 |
| Colonic neoplasms | D003110 | — | C18 | — | — | 1 | 1 | 1 | 3 |
Show 20 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Abdominal pain | D015746 | EFO_0003766 | R10.9 | 2 | 1 | 1 | — | 1 | 5 |
| Colorectal neoplasms | D015179 | — | — | — | — | 1 | — | 4 | 5 |
| Stomach diseases | D013272 | — | — | — | 1 | 1 | — | 2 | 4 |
| Vomiting | D014839 | — | R11.1 | — | — | 1 | — | 1 | 2 |
| Hemorrhage | D006470 | MP_0001914 | R58 | 1 | — | 1 | — | — | 2 |
| Gastrointestinal hemorrhage | D006471 | — | K92.2 | 1 | — | 1 | — | — | 2 |
| Flatulence | D005414 | — | R14.3 | — | — | 2 | — | — | 2 |
| Constipation | D003248 | — | K59.0 | — | 1 | 1 | — | — | 2 |
| Hypertension | D006973 | EFO_0000537 | I10 | — | 2 | 2 | — | — | 2 |
| Portal hypertension | D006975 | EFO_0000666 | K76.6 | — | 2 | 2 | — | — | 2 |
Show 8 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Gastrointestinal diseases | D005767 | — | — | — | 1 | — | — | 3 | 4 |
| Digestive system diseases | D004066 | EFO_0000405 | K92.9 | — | 1 | — | — | 3 | 4 |
| Digestive system endoscopy | D016145 | — | — | — | 1 | — | — | 2 | 3 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | — | 1 | — | — | — | 1 |
| Ovarian epithelial carcinoma | D000077216 | — | — | — | 1 | — | — | — | 1 |
| Pathologic complete response | D000095384 | — | — | — | 1 | — | — | — | 1 |
| Otitis media | D010033 | EFO_0004992 | H66.9 | — | 1 | — | — | — | 1 |
| Otitis | D010031 | — | — | — | 1 | — | — | — | 1 |
| Diabetes complications | D048909 | — | — | — | 1 | — | — | — | 1 |
| Macular edema | D008269 | — | — | — | 1 | — | — | — | 1 |
Show 4 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hiv infections | D015658 | EFO_0000764 | B20 | 2 | — | — | — | — | 2 |
| Traumatic brain injuries | D000070642 | — | S06 | 1 | — | — | — | — | 1 |
| Brain concussion | D001924 | — | S06.0 | 1 | — | — | — | — | 1 |
| Brain injuries | D001930 | — | S06.9 | 1 | — | — | — | — | 1 |
| Post-traumatic stress disorders | D013313 | EFO_0001358 | F43.1 | 1 | — | — | — | — | 1 |
| Traumatic stress disorders | D040921 | — | — | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Mitral valve insufficiency | D008944 | — | — | — | — | — | — | 1 | 1 |
| Cough | D003371 | — | R05 | — | — | — | — | 1 | 1 |
| Chronic cough | D000096822 | — | R05.3 | — | — | — | — | 1 | 1 |
| Polyps | D011127 | EFO_0000662 | — | — | — | — | — | 1 | 1 |
| Gastroscopy | D005773 | — | — | — | — | — | — | 1 | 1 |
| Covid-19 | D000086382 | — | U07.1 | — | — | — | — | 1 | 1 |
| Lactose intolerance | D007787 | — | E73 | — | — | — | — | 1 | 1 |
| Syndrome | D013577 | — | — | — | — | — | — | 1 | 1 |
| Precancerous conditions | D011230 | — | — | — | — | — | — | 1 | 1 |
| Urinary retention | D016055 | — | R33 | — | — | — | — | 1 | 1 |
Show 9 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Simethicone-cellulose |
| INN | — |
| Description | Simeticone (INN), also known as simethicone (USAN), is an anti-foaming agent used to reduce bloating, discomfort or pain caused by excessive gas.
|
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | 8050-81-5 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1201493 |
| ChEBI ID | — |
| PubChem CID | 6433516 |
| DrugBank | DB09512 |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 2 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use